rs2298432

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002745.5(MAPK1):​c.*9+295T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.693 in 205,208 control chromosomes in the GnomAD database, including 51,389 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.72 ( 40493 hom., cov: 32)
Exomes 𝑓: 0.63 ( 10896 hom. )

Consequence

MAPK1
NM_002745.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.25

Publications

36 publications found
Variant links:
Genes affected
MAPK1 (HGNC:6871): (mitogen-activated protein kinase 1) This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]
MAPK1 Gene-Disease associations (from GenCC):
  • Noonan syndrome 13
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.922 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAPK1NM_002745.5 linkc.*9+295T>G intron_variant Intron 8 of 8 ENST00000215832.11 NP_002736.3
MAPK1NM_138957.3 linkc.*304T>G downstream_gene_variant NP_620407.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAPK1ENST00000215832.11 linkc.*9+295T>G intron_variant Intron 8 of 8 1 NM_002745.5 ENSP00000215832.7
MAPK1ENST00000491588.1 linkn.234+295T>G intron_variant Intron 1 of 1 2
MAPK1ENST00000398822.7 linkc.*304T>G downstream_gene_variant 1 ENSP00000381803.3

Frequencies

GnomAD3 genomes
AF:
0.715
AC:
108700
AN:
152020
Hom.:
40430
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.930
Gnomad AMI
AF:
0.607
Gnomad AMR
AF:
0.754
Gnomad ASJ
AF:
0.679
Gnomad EAS
AF:
0.492
Gnomad SAS
AF:
0.618
Gnomad FIN
AF:
0.578
Gnomad MID
AF:
0.731
Gnomad NFE
AF:
0.623
Gnomad OTH
AF:
0.726
GnomAD4 exome
AF:
0.631
AC:
33472
AN:
53070
Hom.:
10896
AF XY:
0.630
AC XY:
17243
AN XY:
27386
show subpopulations
African (AFR)
AF:
0.924
AC:
1659
AN:
1796
American (AMR)
AF:
0.756
AC:
1407
AN:
1860
Ashkenazi Jewish (ASJ)
AF:
0.680
AC:
1508
AN:
2218
East Asian (EAS)
AF:
0.456
AC:
1752
AN:
3840
South Asian (SAS)
AF:
0.614
AC:
1502
AN:
2448
European-Finnish (FIN)
AF:
0.597
AC:
1003
AN:
1680
Middle Eastern (MID)
AF:
0.733
AC:
198
AN:
270
European-Non Finnish (NFE)
AF:
0.624
AC:
22109
AN:
35404
Other (OTH)
AF:
0.657
AC:
2334
AN:
3554
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
600
1200
1801
2401
3001
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.715
AC:
108824
AN:
152138
Hom.:
40493
Cov.:
32
AF XY:
0.712
AC XY:
52983
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.930
AC:
38648
AN:
41550
American (AMR)
AF:
0.754
AC:
11532
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.679
AC:
2357
AN:
3470
East Asian (EAS)
AF:
0.492
AC:
2545
AN:
5174
South Asian (SAS)
AF:
0.618
AC:
2978
AN:
4820
European-Finnish (FIN)
AF:
0.578
AC:
6103
AN:
10552
Middle Eastern (MID)
AF:
0.735
AC:
216
AN:
294
European-Non Finnish (NFE)
AF:
0.623
AC:
42362
AN:
67968
Other (OTH)
AF:
0.725
AC:
1529
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1463
2927
4390
5854
7317
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
808
1616
2424
3232
4040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.650
Hom.:
80042
Bravo
AF:
0.737

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.041
DANN
Benign
0.31
PhyloP100
-3.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2298432; hg19: chr22-22123189; API